David Dye, in Chester, UT - Social Worker

David Dye, is a Social Worker - Clinical based in Chester, Utah. David Dye is licensed to practice in Utah (license number 266252-3501) and his current practice location is 14430 North 2820 East, Chester, Utah. He can be reached at his office (for appointments etc.) via phone at (385) 236-1382.

NPI number for David Dye is 1326634429 and his current mailing address is Hc 13 Box 3086, Chester, Utah. He does not participate in medicare program and thus does not accept medicare assignments. His NPI Number is 1326634429.

Contact Information

	David Dye,
	14430 North 2820 East, Chester, UT 84623-5000
	(385) 236-1382
	Not Available

Healthcare Provider's Profile

Full Name	David Dye
Gender	Male
Speciality	Social Worker - Clinical
Location	14430 North 2820 East, Chester, Utah
Accepts Medicare Assignments	Does not participate in Medicare Program. He may not accept medicare assignment.

NPI Data:

NPI Number: 1326634429
Provider Enumeration Date: 12/14/2020
Last Update Date: 12/14/2020

Medical Identifiers

Medical identifiers for David Dye such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1326634429	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
1041C0700X	Social Worker - Clinical	266252-3501 (Utah)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. David Dye is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
David Dye, Hc 13 Box 3086, Chester, UT 84623-5000 Ph: (385) 236-1382	David Dye, 14430 North 2820 East, Chester, UT 84623-5000 Ph: (385) 236-1382

News Archive

First-of-its-kind map of recombination hotspots in a multi-celled organism

Researchers have zoomed in on mouse chromosomes to map hotspots of genetic recombination - sites where DNA breaks and reforms to shuffle genes. The findings of the scientists at the National Institutes of Health and Uniformed Services University of Health Sciences (USU) have the potential to improve the detection of genes linked to disease and to help understand the root causes of genetic abnormalities.

Declining performance of muscles linked to harmful byproducts of air we breathe

If you think the air outside is polluted, a new research report in the September 2009 issue of the journal Genetics (http://www.genetics.org) might make you to think twice about the air inside our bodies too. That's because researchers show how about 3 percent of the air we breathe gets converted into harmful superoxides, which ultimately harm our muscles.

Scientists develop NIA assay to determine drug's differential effects in tumor cells

A novel technology can make nanoscale protein measurements, which scientists can use in clinical trials to learn how drugs work.We are making progress toward the goal of understanding how drugs work in different individuals, said Alice C. Fan, M.D., instructor in the division of oncology at Stanford University School of Medicine.

Comprehensive approaches to understand the interaction of H1N1 strains with human cells

Scientists have generated hundreds of new leads in the fight against the H1N1 flu pandemic, according to two new studies published online December 17th in the journal Cell, a Cell Press publication.

Fullerene compounds can effectively kill non-small-cell lung carcinoma cells

The team of scientists from Skoltech Center for Energy Science and Technology, the Institute for Problems of Chemical Physics of Russian Academy of Sciences and National Taiwan University have discovered that fullerene compounds can effectively kill non-small-cell lung carcinoma cells and found out the mechanisms behind their anti-tumor activity.

David Dye, - Clinical Social Worker in Chester, UT